genedrive awarded test kit grant
DEVOTE grant will allow acute care patient access and a supporting infrastructure for the company
Read Moreby John Pinching | Jun 16, 2023 | News | 0
DEVOTE grant will allow acute care patient access and a supporting infrastructure for the company
Read Moreby John Pinching | Jun 14, 2023 | News | 0
Preliminary data has shown excellent safety, while also demonstrating proof of mechanism
Read Moreby John Pinching | Jun 8, 2023 | News | 0
Emergence of quick test follows recent dramatic increase in sexually transmitted infections
Read Moreby John Pinching | Mar 20, 2023 | News | 0
Company will also operate work on particular initiatives across an additional five neonatal sites
Read Moreby John Pinching | Mar 15, 2023 | News | 0
Lyophilized PCR reaction bead reduces the cost of transport and extends shelf life for the test
Read Moreby John Pinching | Apr 12, 2022 | News | 0
Novacyt’s second direct-to-PCR test is the third product to be added to the Coronavirus Test Device Approvals (CTDA) register of approved products
Read Moreby Selina McKee | Sep 2, 2020 | News | 0
The test can typically identify SARS-CoV-2 infection within 15 minutes
Read Moreby Selina McKee | Aug 28, 2020 | News | 0
FoundationOne Liquid CDx analyses more than 300 cancer-related genes and multiple genomic signatures to help inform treatment decisions for all solid tumour cancers
Read Moreby Selina McKee | May 15, 2020 | News | 0
Staff without specific training to draw arterial blood can use Roche v-TAC for blood gas analysis
Read Moreby Selina McKee | May 6, 2020 | News | 0
The Scottish government has given funds £101,903 to support the project
Read Moreby Selina McKee | May 1, 2020 | News | 0
The prototype test is based on the fact that sugars coat all human cells
Read Moreby Anna Smith | Jan 17, 2019 | News | 0
Queen’s University researchers have developed a new test to detect disease and infection that could save time, money and possibly lives.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
